万泰生物(603392.SH)：戊肝疫苗已在印度实现销售
WANTAI BIOLOGICALWANTAI BIOLOGICAL(SH:603392) Ge Long Hui·2025-12-30 09:25

Group 1 - The core point of the article is that Wantai Biological Pharmacy (万泰生物) has successfully launched its hepatitis E vaccine in the Indian market [1] Group 2 - The vaccine's sales in India mark a significant milestone for the company, indicating its expansion into international markets [1]